| Literature DB >> 35694882 |
Alicia K Matthews1, Marcus Murray2, Josef Ben Levi3, David Odell4, Rohan Jeremiah1, LeAndre Moore2, Damilola Oyaluade5, Alexis Chappel3, Larisa Burke1, Karriem Watson6.
Abstract
This article describes an educational program to engage African American men as citizen scientists (CSs) and future research partners in a lung cancer screening project. We provide an overview of the curriculum used, the structure and format of the educational sessions, and associated educational outcomes. Furthermore, we describe lessons learned in the engagement of African American men as CS in community-based lung-health equity research. The CS educational program included five group-based sessions delivered through zoom. The educational curriculum was adapted from the University of Florida Citizen Scientist program and tailored to address lung health and the contextual experiences of African American men. Each session lasted 90 minutes. Pre- and post-test measures were collected to examine changes in knowledge, comfort, health literacy, research interests, and medical mistrust. Eight African American men completed the CS educational program. Attendance rates were high for each session (100%). Seven participants completed additional human subject research certification. Improvements were observed from pre- to post-test in participants' level of knowledge, comfort, and health literacy but not medical mistrust. CS reported the most interest in participating in research aimed to identify important community strengths and problems. Study findings suggest that it was feasible to deliver an online citizen scientist educational program designed to prepare participants to serve as partners in a lung cancer screening intervention for African American men. Results suggest the educational program has the potential to improve key outcomes including completion of regulatory training and increased research-related knowledge, comfort, and health literacy.Entities:
Keywords: African American men; citizen scientist; educational curriculum; health care issues; health inequality/disparity; lung cancer
Mesh:
Year: 2022 PMID: 35694882 PMCID: PMC9201322 DOI: 10.1177/15579883221099417
Source DB: PubMed Journal: Am J Mens Health ISSN: 1557-9883
Figure 1.Murray Model of Engaging AA Men in Research, Health Delivery, and Service.
Overview of Educational Curriculum.
| Modules | Session 1 | ||
| Module 1/Session 1 | Learning objectives | Materials covered | Lead |
| Welcome and orientation | Introduce the Citizen Scientist program | 1.1—Welcome and program vision | Research team |
| Discuss the Citizen Scientist curriculum as an open educational resource | 1.2—Citizen Scientists: What are they? What do they do? | ||
| Describe the activities involved in the Citizen Scientist curriculum | 1.3—New employee orientation (site-specific content) | ||
| 1.4—Intellectual property and confidentiality | |||
| 1.5—Citizen Scientists in action: Forming a mission statement | |||
| Session 2 | |||
| Module 3-4/session 2 | Learning objectives | Materials covered | Lead |
| Sponsored research | Define research | 3.1—Research 101 | Research team |
| Restate the steps in the research process | 3.2—Federal funding for research | ||
| Cite the steps of the research process for which Citizen Scientist’s input is most valuable | 3.3—How to read a research article | ||
| 3.4—Citizen Scientists in action: Research team meeting | |||
| Learning objectives | Materials covered | Lead | |
| Clinical and translational science | Describe translational science | 4.1 Translational sciences 101 | Research team |
| Articulate how a Citizen Scientists can help shape translational science projects | 4.2—Types of research | ||
| Explain the ultimate goal of translational science | 4.3—Case study: Citizen Scientist role in translational science | ||
| 4.4—Citizen Scientists in action: Research study review | |||
| Medical mistrust in the African American community: The early origins | History of institutional racism and the exploitation of African Americans to advance medicine | Pillars of American medicine | Dr Levi |
| Make apparent how medical mistrust toward the medical profession has a long and uncomfortable history among African Americans who still bear the scars of those times in their memory and personal experiences. | Critical Race Theory | ||
| Explore cases studies of how enslaved Africans were used as inexhaustive supplies of bodies for physicians of the antebellum era to learn human anatomy | All case studies | ||
| Session 3 | |||
| Module 2/session 3 | Learning objectives | Materials covered | Lead |
| Research privacy, protection, and ethics | Discuss the importance of an Institutional Review Board (IRB) | 2.1—IRBs and Human Subjects Research | Research team |
| Human subject in research | Express the difference between a human and non-human research subject | 2.2—Research Ethics | |
| Information privacy and security | List the different types of IRB approval for research studies | 2.3—Informed Consent | |
| 2.4—Consent for Research vs Clinical Care | |||
| 2.5—Citizen Scientists in Action: Working as a Citizen Scientist | |||
| Lung cancer 101 | Understand lung cancer screening and treatment of lung cancer quality, access to care, opportunities | Lung cancer as a public health issue and surgical standard care | Dr Odell |
| Understanding the stages of lung cancer and its impact on care and recovery | |||
| Research disparity in lung cancer screening | |||
| Lung cancer radiation historical trends | |||
| Lung cancer screening guidelines historical trends | |||
| Technology advancement and disparities in care | |||
| Session 4 | |||
| Module 5/session 4 | Learning objectives | Materials covered | Lead |
| Reading and accessing research materials | Understanding research language | 5.4—Accessing a Primary Research Article | Research team |
| Reviewing research materials | 5.5—Reading a Primary Research Article | ||
| Questioning validity of research materials | |||
| Learning objectives | Materials covered | Lead | |
| Enrollment disparities in cancer clinical trials | Understand how cancer doctors choose which treatment to recommend to patients | Time of extraordinary discoveries in cancer science | Dr Ryan Nguyen |
| Review disparities between cancer clinical trial and the United States and University of Illinois Chicago patients populations | Clinical trials and the Food and Drug Administration’s approval pipeline | ||
| Outline barriers to adequate cancer clinical trials | The constant change in treatment guidelines and science and its impact on providers | ||
| Session 5 | |||
| Session 5 | Learning objectives | Materials covered | Lead |
| Review session | Revise key points from the previous four sessions highlighted by Citizen Scientists | Review of the importance of Research. | Research team |
| Review of the difference between an observation study versus a clinical trial. | |||
| Review of research, safety, and protection of human participants. | |||
| Review of the Institutional Review Board. | |||
| Review of research participants’ rights. | |||
| Review of informed consent in research. | |||
| Review of inclusion and exclusion criteria. |
Demographic Characteristics of Participating CS (N = 8).
| Demographic Variables | % | |
|---|---|---|
| Race—African American | 8 | 100.0 |
| Gender—Male | 8 | 100.0 |
| Age | 47.6 | Range = 37–66 |
| Married | 3 | 37.5 |
| Single | 3 | 37.5 |
| Divorced | 2 | 25.0 |
| College 1 to 3 years (some college or technical school) | 5 | 62.5 |
| College 4 years or more (college graduate) | 3 | 37.5 |
| Family size | 3.25 | Range = 1–6 |
| Income | 76,875 | Range = 50,000–130,000 |
| Prior experiencing volunteering or working in the health care or medical field | 3 | 37.5 |
| Prior experience working or volunteering at events that serve community members. | 7 | 87.5 |
Pre- and Post-Test Evaluation Scores (N = 8).
| Construct | Pre-test | Post-test |
|---|---|---|
| Health literacy—% correct | % ( | % ( |
| - The normal range for hemoglobin for a male is 13.3 to 17.2 g/dl. Joe’s hemoglobin is 9.7 g/dl. Is Joe within the normal range? (yes/no) | 100 (8) | 75 (6) |
| - A biopsy of a tumor is done too . . . (remove it/diagnosis it/treat it) | 87.5 (7) | 100 (8) |
| - If a patient has stage 1 cancer, it means the cancer is (localized/in nearby organs/in distant sites) | 62.5 (5) | 100 (8) |
| - The role of a physical therapist is to talk to a patient about their emotional needs (true/false). | 62.5 (5) | 87.5 (7) |
| - A tumor is considered “inoperable” when it cannot be treated with . . . (radiation therapy/surgery/chemotherapy) | 75.0 (6) | 62.5 (5) |
| - Sally will get radiation therapy once a day, Monday through Friday. If Sally has therapy for 4 weeks, how many times will she get radiation therapy? (5/10/20) | 87.5 (7) | 100 (8) |
| Knowledge about health research—mean score | ||
| - Cancer research | 4.4 | 7.0 |
| - Health research | 4.9 | 7.3 |
| - Cancer center | 3.9 | 5.8 |
| - Cancer center programming | 4.0 | 5.6 |
| - Community health issues | 6.9 | 7.8 |
| Interests related to research— % interested | ||
| - Writing or reviewing research study procedures | 50.0 (4) | 62.5 (5) |
| - Analyzing or interpreting research findings | 62.5 (5) | 62.5 (5) |
| - Writing or reviewing funding applications | 75.0 (6) | 75.0 (6) |
| - Helping to decide cancer center priorities | 87.5 (7) | 87.5 (7) |
| - Recruiting individuals to participate in research | 87.5 (7) | 87.5 (7) |
| - Collecting data/information for research studies | 100 (8) | 87.5 (7) |
| - Identifying important community problems | 100 (8) | 100 (8) |
| - Identifying important community strengths | 100 (8) | 100 (8) |
| Comfort— % very comfortable | ||
| - Comfort talking to physicians | 62.5 (5) | 87.5 (7) |
| - Comfort talking with health researchers | 75.0 (6) | 87.5 (7) |
| - Comfort talking to community members about research | 75.0 (6) | 87.5 (7) |
| - Comfort talking to community members about health care | 62.5 (5) | 75.0 (6) |
Pre- and Post-Test Scores on the Medical Mistrust Scale (N = 8).
| Medical mistrust scale | Pre | Post |
|---|---|---|
| You’d better be cautious when dealing with health care organizations. | 2.4 (0.7) | 3.0 (0.5) |
| Patients have sometimes been deceived or misled by health care organizations. | 2.9 (0.6) | 2.8 (0.9) |
| I trust that health care organizations will tell me if a
mistake is made about my treatment. | 2.1 (0.6) | 2.3 (0.5) |
| Health care organizations often want to know more about your business than they need to know. | 2.3 (0.5) | 2.3 (0.9) |
| When health care organizations make mistakes, they usually cover them up. | 2.4 (0.5) | 2.5 (0.8) |
| Health care organizations have sometimes done harmful experiments on patients without their knowledge. | 2.9 (1.1) | 3.5 (0.5) |
| The patient’s medical needs come before other considerations
at health care organizations. | 2.4 (0.5) | 2.3 (0.5) |
| Health care organizations are more concerned about making money than taking care of people. | 2.8 (0.7) | 2.6 (0.9) |
| Health care organizations put the patient’s health first. | 2.6 (0.5) | 2.9 (0.6) |
| Health care organizations do not always keep your information totally private. | 2.4 (0.9) | 2.4 (1.1) |
| Patients should always follow the advice given to them at
health care organizations. | 2.5 (0.5) | 2.3 (0.7) |
| I typically get a second opinion when I am told something about my Health. | 3.1 (0.4) | 3 (0.5) |
| I trust that health care organizations check their staff’s
credentials to make sure they are hiring the best
people. | 1.9 (0.4) | 1.8 (0.5) |
| They know what they are doing at health care
organizations. | 2.1 (0.4) | 1.8 (0.5) |
| Sometimes I wonder if health care organizations really know what they are doing. | 2.6 (0.5) | 2.4 (0.7) |
| Mistakes are common in health care organizations. | 2.4 (0.5) | 2.8 (0.9) |
| I trust that health care organizations keep up with the
latest medical information. | 2 (0.5) | 2 (0.9) |
| Total mean score | 2.4 (0.3) | 2.5 (0.3) |
| Total summed score | 41.6 (5.0) | 42.3 (5.2) |
Notes. Values are mean (SD). Scores range from 1 to 4, with four representing the most mistrust.
Represents reversed coded items.